MAOB and Parkinson disease: Hence, most approved PD drugs [including levodopa, dopamine agonists, catechol-O-methyl transferase (COMT) inhibitors, and monoamine oxidase-B inhibitors (MAOB-Is)] are thought to alleviate symptoms by enhancing levels of dopamine or inhibiting its metabolism in specific brain regions.